Study Supports Use Of MTWA Test As Predictor Of Sudden Cardiac Death

Cambridge Heart, Inc. (OTCBB-CAMH), announced that results of a PREVENT-SCD trial, presented during a American Heart Association Scientific Sessions in Orlando, Florida, strengthen a worth of a Microvolt T-wave Alternans (MTWA) exam in identifying patients during risk of remarkable cardiac death (SCD).